The cost of cancer care is often a major source of stress for people with cancer. For some, these costs force them to make major lifestyle and medical care changes. Studies presented at both ASCO’s Palliative Care in Oncology and Quality Care Symposia shed more light on the financial challenges of cancer.
Breast cancer advocate Jody Schoger shares her experiences of presenting a poster and attending sessions at the 2014 Breast Cancer Symposium.
For early-stage breast cancer, doctors generally recommend surgery to remove the tumor. But choosing between a lumpectomy and mastectomy can sometimes be difficult. Deanna Attai, MD, FACS, a breast cancer surgeon, provides information and advice to help women talk with their doctors about this decision.
A large Canadian study finds that simply adding a doctor-signed letter to standard postcard reminders increases the chance that women will have their overdue mammogram screenings.
Learn how Angelina Jolie sharing her decision to have a preventive double mastectomy because she was a carrier of the BRCA mutation affected genetic counseling referrals and genetic testing rates at a Canadian cancer center.
New Insight on the Factors Affecting Local and Regional Recurrence from the 2014 Breast Cancer Symposium
Learn more about the results of a large study that has identified two factors that may help predict the chance that breast cancer will come back in the breast or nearby areas better than the cancer’s stage.
Get highlights of two studies that provide insight into why some women with early-stage breast cancer choose to have a double mastectomy and the risk of complications they may experience after this surgery.
High temperatures can cause issues for people receiving cancer treatment. Get some tips on staying cool and hydrated this summer.
Jane O. Smith offers insights about embracing and expressing the physical (and emotional) changes that happen after a mastectomy and other types of cancer treatment.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.